Results 151 to 160 of about 247,613 (164)

[Research progress on the mechanisms and optimization strategies of mesenchymal stem cell-derived exosomes in the treatment of liver diseases]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li XR, Niu B, Zhang LY.
europepmc   +1 more source

[Scutellarin improves metabolic dysfunction-associated steatotic liver disease in rats by regulating MMP7 and LCN2]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Ma Y, Guo L, Wang J, Xiao W, Lv Y, Fan X.   +5 more
europepmc   +1 more source

[Research progress and future prospects for artificial intelligence in the diagnosis and treatment of fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Lin YY, Liu F, Rao HY.
europepmc   +1 more source

[Research advances in autoimmune liver disease in 2025: toward precision regulation and personalized treatment]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Shang YL, Han Y.
europepmc   +1 more source

[Role of Kupffer cells in liver regeneration with metabolic associated fatty liver disease in mice]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang TW, Liu L, Wang SY, Cheng LL, Wang X, Cao YN, Wang YF, Yang LM.   +7 more
europepmc   +1 more source

[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wu ST, Lu XL.
europepmc   +1 more source

[Research progress on autoimmune liver disease in 2024]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zheng LH, Han Y.
europepmc   +1 more source

[Risk Factors and Etiology of Pulmonary Fungal Infection in Patients With End-Stage Liver Disease]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Liu Q, Li J, Wang W, Zhao X.
europepmc   +1 more source